The corporate-backed firm is launching a fund called Bharat in order to expand its focus from clean energy to sectors like healthcare and agribusiness.

Roche and Novo-backed Corvus Pharmaceuticals priced its IPO at the lower end of its range and raised $70.5m when it floated on Nasdaq yesterday.

Baxalta's corporate venturing unit contributed to the $10m second tranche of the autoimmune disease drug developer's series A round, expected to close at $26m.

The heart imaging technology company took its overall funding to $135m in a round that included returning investor GE Ventures.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

Evotec has spun out Topas Therapeutics, which is working on treatments for conditions including MS, also contributing to a series A round.

Maxwell Health has closed a $22m series C round backed by the Guardian Life Insurance Company of America, Sun Life Financial and Cambia Health Solutions.

SoftBank and Shanghai Charity Foundation invested $21m in Shanghai Pharmaceutical Big Health Yunshang, formed by Shanghai Pharmaceuticals.